-
1
-
-
0028243778
-
Allelic loss in locally metastatic, multisampled prostate cancer
-
Sakr, W. A., Macoska, J. A., Benson, P., Grignon, D. J., Wolman, S. R., Pontes, J. E., and Crissman, J. D. Allelic loss in locally metastatic, multisampled prostate cancer. Cancer Res., 54: 3273-3277, 1994.
-
(1994)
Cancer Res.
, vol.54
, pp. 3273-3277
-
-
Sakr, W.A.1
Macoska, J.A.2
Benson, P.3
Grignon, D.J.4
Wolman, S.R.5
Pontes, J.E.6
Crissman, J.D.7
-
2
-
-
0028849282
-
Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization
-
Qian, J., Bostwick, D. G., Takahashi, S., Borell, T. J., Herath, J. F., Lieber, M. M., and Jenkins, R. B. Chromosomal anomalies in prostatic intraepithelial neoplasia and carcinoma detected by fluorescence in situ hybridization. Cancer Res., 55: 5408-5414, 1995.
-
(1995)
Cancer Res.
, vol.55
, pp. 5408-5414
-
-
Qian, J.1
Bostwick, D.G.2
Takahashi, S.3
Borell, T.J.4
Herath, J.F.5
Lieber, M.M.6
Jenkins, R.B.7
-
3
-
-
0028912408
-
Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer
-
Thompson, T. C., Park, S. H., Timme, T. L., Ren, C., Eastham, J. A., Donehower, L. A., Bradley, A., Kadmon, D., and Yang, G. Loss of p53 function leads to metastasis in ras+myc-initiated mouse prostate cancer. Oncogene, 10: 869-879, 1995.
-
(1995)
Oncogene
, vol.10
, pp. 869-879
-
-
Thompson, T.C.1
Park, S.H.2
Timme, T.L.3
Ren, C.4
Eastham, J.A.5
Donehower, L.A.6
Bradley, A.7
Kadmon, D.8
Yang, G.9
-
4
-
-
0028123687
-
Demonstration of a rational strategy for human prostate cancer gene therapy
-
Sanda, M. G., Ayyagari, S. R., Jaffee, E. M., Epstein, J. I., Clift, S. L., Cohen, L. K., Dranoff, G., Pardoll, D. M., Mulligan, R. C., and Simons, J. W. Demonstration of a rational strategy for human prostate cancer gene therapy. J. Urol., 151: 622-628, 1994.
-
(1994)
J. Urol.
, vol.151
, pp. 622-628
-
-
Sanda, M.G.1
Ayyagari, S.R.2
Jaffee, E.M.3
Epstein, J.I.4
Clift, S.L.5
Cohen, L.K.6
Dranoff, G.7
Pardoll, D.M.8
Mulligan, R.C.9
Simons, J.W.10
-
5
-
-
0032741439
-
Induction of immunity to prostate cancer antigens: Results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer
-
Simons, J. W., Mikhak, B., Chang, J. F., DeMarzo, A. M., Carducci, M. A., Lim, M., Weber, C. E., Baccala, A. A., Goemann, M. A., Clift, S. M., Ando, D. G., Levitsky, H. I., Cohen, L. K., Sanda, M. G., Mulligan, R. C., Partin, A. W., Carter, H. B., Piantadosi, S., Marshall, F. F., and Nelson, W. G. Induction of immunity to prostate cancer antigens: results of a clinical trial of vaccination with irradiated autologous prostate tumor cells engineered to secrete granulocyte-macrophage colony-stimulating factor using ex vivo gene transfer. Cancer Res., 59: 5160-5168, 1999.
-
(1999)
Cancer Res.
, vol.59
, pp. 5160-5168
-
-
Simons, J.W.1
Mikhak, B.2
Chang, J.F.3
DeMarzo, A.M.4
Carducci, M.A.5
Lim, M.6
Weber, C.E.7
Baccala, A.A.8
Goemann, M.A.9
Clift, S.M.10
Ando, D.G.11
Levitsky, H.I.12
Cohen, L.K.13
Sanda, M.G.14
Mulligan, R.C.15
Partin, A.W.16
Carter, H.B.17
Piantadosi, S.18
Marshall, F.F.19
Nelson, W.G.20
more..
-
6
-
-
0034043167
-
Priming tissue-specific cellular immunity in a Phase I trial of autologous dendritic cells for prostate cancer
-
Burch, P. A., Breen, J. K., Buckner, J. C., Gastineau, D. A., Kaur, J. A., Laus, R. L., Padley, D. J., Peshwa, M. V., Pitot, H. C., Richardson, R. L., Smits, B. J., Sopapan, P., Strang, G., Valone, F. H., and Vuk-Pavlovic, S. Priming tissue-specific cellular immunity in a Phase I trial of autologous dendritic cells for prostate cancer. Clin. Cancer Res., 6: 2175-2182, 2000.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 2175-2182
-
-
Burch, P.A.1
Breen, J.K.2
Buckner, J.C.3
Gastineau, D.A.4
Kaur, J.A.5
Laus, R.L.6
Padley, D.J.7
Peshwa, M.V.8
Pitot, H.C.9
Richardson, R.L.10
Smits, B.J.11
Sopapan, P.12
Strang, G.13
Valone, F.H.14
Vuk-Pavlovic, S.15
-
7
-
-
0035869523
-
Dendritic cells injected via different routes induce immunity in cancer patients
-
Fong, L., Brockstedt, D., Benike, C., Wu, L., and Engleman, E. G. Dendritic cells injected via different routes induce immunity in cancer patients. J. Immunol., 166: 4254-4259, 2001.
-
(2001)
J. Immunol.
, vol.166
, pp. 4254-4259
-
-
Fong, L.1
Brockstedt, D.2
Benike, C.3
Wu, L.4
Engleman, E.G.5
-
8
-
-
0034554863
-
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells
-
Small, E. J., Fratesi, P., Reese, D. M., Strang, G., Laus, R., Peshwa, M. V., and Valone, F. H. Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cells. J. Clin. Oncol., 18: 3894-3903, 2000.
-
(2000)
J. Clin. Oncol.
, vol.18
, pp. 3894-3903
-
-
Small, E.J.1
Fratesi, P.2
Reese, D.M.3
Strang, G.4
Laus, R.5
Peshwa, M.V.6
Valone, F.H.7
-
9
-
-
0032892718
-
Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: A Phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease
-
Murphy, G. P., Tjoa, B. A., Simmons, S. J., Jarisch, J., Bowes, V. A., Ragde, H., Rogers, M., Elgamal, A., Kenny, G. M., Cobb, O. E., Ireton, R. C., Troychak, M. J., Salgaller, M. L., and Boynton, A. L. Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a Phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease. Prostate, 38: 73-78, 1999.
-
(1999)
Prostate
, vol.38
, pp. 73-78
-
-
Murphy, G.P.1
Tjoa, B.A.2
Simmons, S.J.3
Jarisch, J.4
Bowes, V.A.5
Ragde, H.6
Rogers, M.7
Elgamal, A.8
Kenny, G.M.9
Cobb, O.E.10
Ireton, R.C.11
Troychak, M.J.12
Salgaller, M.L.13
Boynton, A.L.14
-
10
-
-
0034652619
-
Dendritic cell-based immunotherapy of prostate cancer: Immune monitoring of a Phase II clinical trial
-
Lodge, P. A., Jones, L. A., Bader, R. A., Murphy, G. P., and Salgaller, M. L. Dendritic cell-based immunotherapy of prostate cancer: immune monitoring of a Phase II clinical trial. Cancer Res., 60: 829-833, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 829-833
-
-
Lodge, P.A.1
Jones, L.A.2
Bader, R.A.3
Murphy, G.P.4
Salgaller, M.L.5
-
11
-
-
0036167308
-
Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors
-
Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., and Vieweg, J. Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors. J. Clin. Investig., 109: 409-417, 2002.
-
(2002)
J. Clin. Investig.
, vol.109
, pp. 409-417
-
-
Heiser, A.1
Coleman, D.2
Dannull, J.3
Yancey, D.4
Maurice, M.A.5
Lallas, C.D.6
Dahm, P.7
Niedzwiecki, D.8
Gilboa, E.9
Vieweg, J.10
-
12
-
-
0034652624
-
Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells
-
Boczkowski, D., Nair, S. K., Nam, J. H., Lyerly, H. K., and Gilboa, E. Induction of tumor immunity and cytotoxic T lymphocyte responses using dendritic cells transfected with messenger RNA amplified from tumor cells. Cancer Res., 60: 1028-1034, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 1028-1034
-
-
Boczkowski, D.1
Nair, S.K.2
Nam, J.H.3
Lyerly, H.K.4
Gilboa, E.5
-
13
-
-
0035284901
-
Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA
-
Heiser, A., Maurice, M. A., Yancey, D. R., Wu, N. Z., Dahm, P., Pruitt, S. K., Boczkowski, D., Nair, S. K., Ballo, M. S., Gilboa, E., and Vieweg, J. Induction of polyclonal prostate cancer-specific CTL using dendritic cells transfected with amplified tumor RNA. J. Immunol., 166: 2953-2960, 2001.
-
(2001)
J. Immunol.
, vol.166
, pp. 2953-2960
-
-
Heiser, A.1
Maurice, M.A.2
Yancey, D.R.3
Wu, N.Z.4
Dahm, P.5
Pruitt, S.K.6
Boczkowski, D.7
Nair, S.K.8
Ballo, M.S.9
Gilboa, E.10
Vieweg, J.11
-
14
-
-
0037380052
-
Therapeutic targets for metastatic prostate cancer
-
Timme, T. L., Satoh, T., Tahir, S. A., Wang, H., Teh, B. S., Butler, E. B., Miles, B. J., Amato, R. J., Kadmon, D., and Thompson, T. C. Therapeutic targets for metastatic prostate cancer. Curr. Drug Targets, 4: 251-261, 2003.
-
(2003)
Curr. Drug Targets
, vol.4
, pp. 251-261
-
-
Timme, T.L.1
Satoh, T.2
Tahir, S.A.3
Wang, H.4
Teh, B.S.5
Butler, E.B.6
Miles, B.J.7
Amato, R.J.8
Kadmon, D.9
Thompson, T.C.10
-
15
-
-
0036081075
-
Gene therapy for prostate cancer
-
Gdor, Y., Timme, T. L., Miles, B. J., Kadmon, D., and Thompson, T. C. Gene therapy for prostate cancer. Expert Rev. Anticancer Ther., 2: 309-321, 2002.
-
(2002)
Expert Rev. Anticancer Ther.
, vol.2
, pp. 309-321
-
-
Gdor, Y.1
Timme, T.L.2
Miles, B.J.3
Kadmon, D.4
Thompson, T.C.5
-
16
-
-
0035346833
-
In situ gene therapy for prostate cancer: Immunomodulatory approaches
-
Thompson, T. C., Timme, T. L., Ebara, S., Satoh, T., Yang, G., Wang, J., Miles, B. J., Ayala, G., Wheeler, T. M., and Kadmon, D. In situ gene therapy for prostate cancer: immunomodulatory approaches. Expert Opin. Biol. Ther., 1: 481-495, 2001.
-
(2001)
Expert Opin. Biol. Ther.
, vol.1
, pp. 481-495
-
-
Thompson, T.C.1
Timme, T.L.2
Ebara, S.3
Satoh, T.4
Yang, G.5
Wang, J.6
Miles, B.J.7
Ayala, G.8
Wheeler, T.M.9
Kadmon, D.10
-
17
-
-
0029924404
-
Prostate cancer gene therapy: Herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models
-
Eastham, J. A., Chen, S. H., Sehgal, I., Yang, G., Timme, T. L., Hall, S. J., Woo, S. L., and Thompson, T. C. Prostate cancer gene therapy: herpes simplex virus thymidine kinase gene transduction followed by ganciclovir in mouse and human prostate cancer models. Hum. Gene Ther., 7: 515-523, 1996.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 515-523
-
-
Eastham, J.A.1
Chen, S.H.2
Sehgal, I.3
Yang, G.4
Timme, T.L.5
Hall, S.J.6
Woo, S.L.7
Thompson, T.C.8
-
18
-
-
0032618858
-
Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer
-
Hall, S. J., Mutchnik, S. E., Yang, G., Timme, T. L., Nasu, Y., Bangma, C. H., Woo, S. L., Shaker, M., and Thompson, T. C. Cooperative therapeutic effects of androgen ablation and adenovirus-mediated herpes simplex virus thymidine kinase gene and ganciclovir therapy in experimental prostate cancer. Cancer Gene Ther., 6: 54-63, 1999.
-
(1999)
Cancer Gene Ther.
, vol.6
, pp. 54-63
-
-
Hall, S.J.1
Mutchnik, S.E.2
Yang, G.3
Timme, T.L.4
Nasu, Y.5
Bangma, C.H.6
Woo, S.L.7
Shaker, M.8
Thompson, T.C.9
-
19
-
-
0032020501
-
Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice
-
Timme, T. L., Hall, S. J., Barrios, R., Woo, S. L., Aguilar-Cordova, E., and Thompson, T. C. Local inflammatory response and vector spread after direct intraprostatic injection of a recombinant adenovirus containing the herpes simplex virus thymidine kinase gene and ganciclovir therapy in mice. Cancer Gene Ther., 5: 74-82, 1998.
-
(1998)
Cancer Gene Ther.
, vol.5
, pp. 74-82
-
-
Timme, T.L.1
Hall, S.J.2
Barrios, R.3
Woo, S.L.4
Aguilar-Cordova, E.5
Thompson, T.C.6
-
20
-
-
0035675839
-
In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter
-
Pramudji, C., Shimura, S., Ebara, S., Yang, G., Wang, J., Ren, C., Yuan, Y., Tahir, S. A., Timme, T. L., and Thompson, T. C. In situ prostate cancer gene therapy using a novel adenoviral vector regulated by the caveolin-1 promoter. Clin. Cancer Res., 7: 4272-4279, 2001.
-
(2001)
Clin. Cancer Res.
, vol.7
, pp. 4272-4279
-
-
Pramudji, C.1
Shimura, S.2
Ebara, S.3
Yang, G.4
Wang, J.5
Ren, C.6
Yuan, Y.7
Tahir, S.A.8
Timme, T.L.9
Thompson, T.C.10
-
21
-
-
0036968378
-
Gene therapy for prostate cancer: Toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters
-
Ebara, S., Shimura, S., Nasu, Y., Kaku, H., Kumon, H., Yang, G., Wang, J., Timme, T. L., Aguilar-Cordova, E., and Thompson, T. C. Gene therapy for prostate cancer: toxicological profile of four HSV-tk transducing adenoviral vectors regulated by different promoters. Prostate Cancer Prostatic Dis., 5: 316-325, 2002.
-
(2002)
Prostate Cancer Prostatic Dis.
, vol.5
, pp. 316-325
-
-
Ebara, S.1
Shimura, S.2
Nasu, Y.3
Kaku, H.4
Kumon, H.5
Yang, G.6
Wang, J.7
Timme, T.L.8
Aguilar-Cordova, E.9
Thompson, T.C.10
-
22
-
-
0033135221
-
In situ gene therapy for adenocarcinoma of the prostate: A Phase I clinical trial
-
Herman, J. R., Adler, H. L., Aguilar-Cordova, E., Rojas-Martinez, A., Woo, S., Timme, T. L., Wheeler, T. M., Thompson, T. C., and Scardino, P. T. In situ gene therapy for adenocarcinoma of the prostate: a Phase I clinical trial. Hum. Gene Ther., 10: 1239-1249, 1999.
-
(1999)
Hum. Gene Ther.
, vol.10
, pp. 1239-1249
-
-
Herman, J.R.1
Adler, H.L.2
Aguilar-Cordova, E.3
Rojas-Martinez, A.4
Woo, S.5
Timme, T.L.6
Wheeler, T.M.7
Thompson, T.C.8
Scardino, P.T.9
-
23
-
-
0033926615
-
Cytopathic effect of in situ gene therapy in prostate cancer
-
Ayala, G., Wheeler, T. M., Shalev, M., Thompson, T. C., Miles, B., Aguilar-Cordova, E., Chakraborty, S., and Kadmon, D. Cytopathic effect of in situ gene therapy in prostate cancer. Hum. Pathol., 31: 866-870, 2000.
-
(2000)
Hum. Pathol.
, vol.31
, pp. 866-870
-
-
Ayala, G.1
Wheeler, T.M.2
Shalev, M.3
Thompson, T.C.4
Miles, B.5
Aguilar-Cordova, E.6
Chakraborty, S.7
Kadmon, D.8
-
24
-
-
0035199415
-
Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy
-
Miles, B. J., Shalev, M., Aguilar-Cordova, E., Timme, T. L., Lee, H. M., Yang, G., Adler, H. L., Kernen, K., Pramudji, C. K., Satoh, T., Gdor, Y., Ren, C., Ayala, G., Wheeler. T. M., Butler, E. B., Kadmon, D., and Thompson, T. C. Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy. Hum. Gene Ther., 12: 1955-1967, 2001.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 1955-1967
-
-
Miles, B.J.1
Shalev, M.2
Aguilar-Cordova, E.3
Timme, T.L.4
Lee, H.M.5
Yang, G.6
Adler, H.L.7
Kernen, K.8
Pramudji, C.K.9
Satoh, T.10
Gdor, Y.11
Ren, C.12
Ayala, G.13
Wheeler, T.M.14
Butler, E.B.15
Kadmon, D.16
Thompson, T.C.17
-
25
-
-
0035501397
-
Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer - A preliminary report
-
Teh, B. S., Aguilar-Cordova, E., Kernen, K., Chou, C. C., Shalev, M., Vlachaki, M. T., Miles, B., Kadmon, D., Mai, W. Y., Caillouet, J., Davis, M., Ayala, G., Wheeler, T., Brady, J., Carpenter, L. S., Lu, H. H., Chiu, J. K., Woo, S. Y., Thompson, T., and Butler, E. B. Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer - a preliminary report. Int. J. Radiat. Oncol. Biol. Phys., 51: 605-613, 2001.
-
(2001)
Int. J. Radiat. Oncol. Biol. Phys.
, vol.51
, pp. 605-613
-
-
Teh, B.S.1
Aguilar-Cordova, E.2
Kernen, K.3
Chou, C.C.4
Shalev, M.5
Vlachaki, M.T.6
Miles, B.7
Kadmon, D.8
Mai, W.Y.9
Caillouet, J.10
Davis, M.11
Ayala, G.12
Wheeler, T.13
Brady, J.14
Carpenter, L.S.15
Lu, H.H.16
Chiu, J.K.17
Woo, S.Y.18
Thompson, T.19
Butler, E.B.20
more..
-
26
-
-
0032996037
-
Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: Suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model
-
Nasu, Y., Bangma, C. H., Hull, G. W., Lee, H. M., Hu, J., Wang, J., McCurdy, M. A., Shimura, S., Yang, G., Timme, T. L., and Thompson, T. C. Adenovirus-mediated interleukin-12 gene therapy for prostate cancer: suppression of orthotopic tumor growth and pre-established lung metastases in an orthotopic model. Gene Ther., 6: 338-349, 1999.
-
(1999)
Gene Ther.
, vol.6
, pp. 338-349
-
-
Nasu, Y.1
Bangma, C.H.2
Hull, G.W.3
Lee, H.M.4
Hu, J.5
Wang, J.6
McCurdy, M.A.7
Shimura, S.8
Yang, G.9
Timme, T.L.10
Thompson, T.C.11
-
27
-
-
0033766179
-
Prostate cancer gene therapy: Comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines
-
Hull, G. W., McCurdy, M. A., Nasu, Y., Bangma, C. H., Yang, G., Shimura, S., Lee, H. M., Wang, J., Albani, J., Ebara, S., Sato, T., Timme, T. L., and Thompson, T. C. Prostate cancer gene therapy: comparison of adenovirus-mediated expression of interleukin 12 with interleukin 12 plus B7-1 for in situ gene therapy and gene-modified, cell-based vaccines. Clin. Cancer Res., 6: 4101-4109, 2000.
-
(2000)
Clin. Cancer Res.
, vol.6
, pp. 4101-4109
-
-
Hull, G.W.1
McCurdy, M.A.2
Nasu, Y.3
Bangma, C.H.4
Yang, G.5
Shimura, S.6
Lee, H.M.7
Wang, J.8
Albani, J.9
Ebara, S.10
Sato, T.11
Timme, T.L.12
Thompson, T.C.13
-
28
-
-
0035061269
-
Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer
-
Nasu, Y., Bangma, C. H., Hull, G. W., Yang, G., Wang, J., Shimura, S., McCurdy, M. A., Ebara, S., Lee, H. M., Timme, T. L., and Thompson, T. C. Combination gene therapy with adenoviral vector-mediated HSV-tk+GCV and IL-12 in an orthotopic mouse model for prostate cancer. Prostate Cancer Prostatic Dis., 4: 44-55, 2001.
-
(2001)
Prostate Cancer Prostatic Dis.
, vol.4
, pp. 44-55
-
-
Nasu, Y.1
Bangma, C.H.2
Hull, G.W.3
Yang, G.4
Wang, J.5
Shimura, S.6
McCurdy, M.A.7
Ebara, S.8
Lee, H.M.9
Timme, T.L.10
Thompson, T.C.11
-
29
-
-
0034667386
-
Reduced infiltration of tumor-associated macrophages in human prostate cancer: Association with cancer progression
-
Shimura, S., Yang, G., Ebara, S., Wheeler, T. M., Frolov, A., and Thompson, T. C. Reduced infiltration of tumor-associated macrophages in human prostate cancer: association with cancer progression. Cancer Res., 60: 5857-5861, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 5857-5861
-
-
Shimura, S.1
Yang, G.2
Ebara, S.3
Wheeler, T.M.4
Frolov, A.5
Thompson, T.C.6
-
30
-
-
0029848051
-
Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12
-
Bramson, J. L., Hitt, M., Addison, C. L., Muller, W. J., Gauldie, J., and Graham, F. L. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. Hum. Gene Ther., 7: 1995-2002, 1996.
-
(1996)
Hum. Gene Ther.
, vol.7
, pp. 1995-2002
-
-
Bramson, J.L.1
Hitt, M.2
Addison, C.L.3
Muller, W.J.4
Gauldie, J.5
Graham, F.L.6
-
31
-
-
0029315806
-
Methods for construction of adenovirus vectors
-
Graham, F. L., and Prevec, L. Methods for construction of adenovirus vectors. Mol. Biotechnol., 3: 207-220, 1995.
-
(1995)
Mol. Biotechnol.
, vol.3
, pp. 207-220
-
-
Graham, F.L.1
Prevec, L.2
-
32
-
-
0034955529
-
Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression
-
Shaker, M. R., Yang, G., Timme, T. L., Park, S. H., Kadmon, D., Ren, C., Ji, X., Lee, H. M., Sehgal, I., Anzano, M., Sporn, M. B., and Thompson, T. C. Dietary 4-HPR suppresses the development of bone metastasis in vivo in a mouse model of prostate cancer progression. Clin. Exp. Metastasis. 18: 429-438, 2000.
-
(2000)
Clin. Exp. Metastasis.
, vol.18
, pp. 429-438
-
-
Shaker, M.R.1
Yang, G.2
Timme, T.L.3
Park, S.H.4
Kadmon, D.5
Ren, C.6
Ji, X.7
Lee, H.M.8
Sehgal, I.9
Anzano, M.10
Sporn, M.B.11
Thompson, T.C.12
-
33
-
-
0035872436
-
Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer
-
Tahir, S. A., Yang, G., Ebara, S., Timme, T. L., Satoh, T., Li, L., Goltsov, A., Itmann, M., Morrisett, J. D., and Thompson, T. C. Secreted caveolin-1 stimulates cell survival/clonal growth and contributes to metastasis in androgen-insensitive prostate cancer. Cancer Res., 61: 3882-3885, 2001.
-
(2001)
Cancer Res.
, vol.61
, pp. 3882-3885
-
-
Tahir, S.A.1
Yang, G.2
Ebara, S.3
Timme, T.L.4
Satoh, T.5
Li, L.6
Goltsov, A.7
Itmann, M.8
Morrisett, J.D.9
Thompson, T.C.10
-
34
-
-
0034109776
-
Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells
-
Lee, H. M., Timme, T. L., and Thompson, T. C. Resistance to lysis by cytotoxic T cells: a dominant effect in metastatic mouse prostate cancer cells. Cancer Res., 60: 1927-1933, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 1927-1933
-
-
Lee, H.M.1
Timme, T.L.2
Thompson, T.C.3
-
35
-
-
18644386765
-
Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk
-
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Hu, J. J., Sterling, D., Lange, E. M., Hawkins, G. A., Turner, A., Ewing, C. M., Faith, D. A., Johnson, J. R., Suzuki, H., Bujnovszky, P., Wiley, K. E., DeMarzo, A. M., Bova, G. S., Chang, B., Hall, M. C., McCullough, D. L., Partin, A. W., Kassabian, V. S., Carpten, J. D., Bailey-Wilson, J. E., Trent, J. M., Ohar, J., Bleecker, E. R., Walsh, P. C., Isaacs, W. B., and Meyers, D. A. Germline mutations and sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Nat. Genet., 32: 321-325, 2002.
-
(2002)
Nat. Genet.
, vol.32
, pp. 321-325
-
-
Xu, J.1
Zheng, S.L.2
Komiya, A.3
Mychaleckyj, J.C.4
Isaacs, S.D.5
Hu, J.J.6
Sterling, D.7
Lange, E.M.8
Hawkins, G.A.9
Turner, A.10
Ewing, C.M.11
Faith, D.A.12
Johnson, J.R.13
Suzuki, H.14
Bujnovszky, P.15
Wiley, K.E.16
DeMarzo, A.M.17
Bova, G.S.18
Chang, B.19
Hall, M.C.20
McCullough, D.L.21
Partin, A.W.22
Kassabian, V.S.23
Carpten, J.D.24
Bailey-Wilson, J.E.25
Trent, J.M.26
Ohar, J.27
Bleecker, E.R.28
Walsh, P.C.29
Isaacs, W.B.30
Meyers, D.A.31
more..
-
36
-
-
0037219568
-
Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk
-
Xu, J., Zheng, S. L., Komiya, A., Mychaleckyj, J. C., Isaacs, S. D., Chang, B., Turner, A. R., Ewing, C. M., Wiley, K. E., Hawkins, G. A., Bleecker, E. R., Walsh, P. C., Meyers, D. A., and Isaacs, W. B. Common sequence variants of the macrophage scavenger receptor 1 gene are associated with prostate cancer risk. Am. J. Hum. Genet., 72: 208-212, 2003.
-
(2003)
Am. J. Hum. Genet.
, vol.72
, pp. 208-212
-
-
Xu, J.1
Zheng, S.L.2
Komiya, A.3
Mychaleckyj, J.C.4
Isaacs, S.D.5
Chang, B.6
Turner, A.R.7
Ewing, C.M.8
Wiley, K.E.9
Hawkins, G.A.10
Bleecker, E.R.11
Walsh, P.C.12
Meyers, D.A.13
Isaacs, W.B.14
-
37
-
-
0034135980
-
Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system
-
Schroers, R., Sinha, I., Segall, H., Schmidt-Wolf, I. G., Rooney, C. M., Brenner, M. K., Sutton, R. E., and Chen, S. Y. Transduction of human PBMC-derived dendritic cells and macrophages by an HIV-1-based lentiviral vector system. Mol. Ther., 1: 171-179, 2000.
-
(2000)
Mol. Ther.
, vol.1
, pp. 171-179
-
-
Schroers, R.1
Sinha, I.2
Segall, H.3
Schmidt-Wolf, I.G.4
Rooney, C.M.5
Brenner, M.K.6
Sutton, R.E.7
Chen, S.Y.8
-
38
-
-
0034004373
-
Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus
-
Kluth, D. C., Erwig, L. P., Pearce, W. P., and Rees, A. J. Gene transfer into inflamed glomeruli using macrophages transfected with adenovirus. Gene Ther., 7: 263-270, 2000.
-
(2000)
Gene Ther.
, vol.7
, pp. 263-270
-
-
Kluth, D.C.1
Erwig, L.P.2
Pearce, W.P.3
Rees, A.J.4
-
39
-
-
0035313470
-
Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis
-
Kluth, D. C., Ainslie, C. V., Pearce, W. P., Finlay, S., Clarke, D., Anegon, I., and Rees, A. J. Macrophages transfected with adenovirus to express IL-4 reduce inflammation in experimental glomerulonephritis. J. Immunol., 166: 4728-4736, 2001.
-
(2001)
J. Immunol.
, vol.166
, pp. 4728-4736
-
-
Kluth, D.C.1
Ainslie, C.V.2
Pearce, W.P.3
Finlay, S.4
Clarke, D.5
Anegon, I.6
Rees, A.J.7
-
40
-
-
0033556011
-
Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12
-
Cavallo, F., Di Carlo, E., Butera, M., Verrua, R., Colombo, M. P., Musiani, P., and Forni, G. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. Cancer Res., 59: 414-421, 1999.
-
(1999)
Cancer Res.
, vol.59
, pp. 414-421
-
-
Cavallo, F.1
Di Carlo, E.2
Butera, M.3
Verrua, R.4
Colombo, M.P.5
Musiani, P.6
Forni, G.7
-
41
-
-
0034649786
-
Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice
-
Boggio, K., Di Carlo, E., Rovero, S., Cavallo, F., Quaglino, E., Lollini, P. L., Nanni, P., Nicoletti, G., Wolf, S., Musiani, P., and Forni, G. Ability of systemic interleukin-12 to hamper progressive stages of mammary carcinogenesis in HER2/neu transgenic mice. Cancer Res., 60: 359-364, 2000.
-
(2000)
Cancer Res.
, vol.60
, pp. 359-364
-
-
Boggio, K.1
Di Carlo, E.2
Rovero, S.3
Cavallo, F.4
Quaglino, E.5
Lollini, P.L.6
Nanni, P.7
Nicoletti, G.8
Wolf, S.9
Musiani, P.10
Forni, G.11
-
42
-
-
0034284460
-
The anti-tumor activity of IL-12: Mechanisms of innate immunity that are model and dose dependent
-
Smyth, M. J., Taniguchi, M., and Street, S. E. The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J. Immunol., 165: 2665-2670, 2000.
-
(2000)
J. Immunol.
, vol.165
, pp. 2665-2670
-
-
Smyth, M.J.1
Taniguchi, M.2
Street, S.E.3
-
43
-
-
0032900383
-
Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer
-
Robertson, M. J., Cameron, C., Atkins, M. B., Gordon, M. S., Lotze, M. T., Sherman, M. L., and Ritz, J. Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancer. Clin. Cancer Res., 5: 9-16, 1999.
-
(1999)
Clin. Cancer Res.
, vol.5
, pp. 9-16
-
-
Robertson, M.J.1
Cameron, C.2
Atkins, M.B.3
Gordon, M.S.4
Lotze, M.T.5
Sherman, M.L.6
Ritz, J.7
-
44
-
-
0035831628
-
Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a Phase I study
-
Kang, W. K., Park, C., Yoon, H. L., Kim, W. S., Yoon, S. S., Lee, M. H., Park, K., Kim, K., Jeong, H. S., Kim, J. A., Nam, S. J., Yang, J. H., Son, Y. I., Back, C. H., Han, J., Ree, H. J., Lee, E. S., Kim, S. H., Kim, D. W., Ahn, Y. C., Huh, S. J., Choe, Y. H., Lee, J. H., Park, M. H., Kong, G. S., Park, E. Y., Kang, Y. K., Bang, Y. J., Paik, N. S., Lee, S. N., Kim, S., Robbins, P. D., Tahara, H., Lotze, M. T., and Park, C. H. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: outcome of a Phase I study. Hum. Gene Ther., 12: 671-684, 2001.
-
(2001)
Hum. Gene Ther.
, vol.12
, pp. 671-684
-
-
Kang, W.K.1
Park, C.2
Yoon, H.L.3
Kim, W.S.4
Yoon, S.S.5
Lee, M.H.6
Park, K.7
Kim, K.8
Jeong, H.S.9
Kim, J.A.10
Nam, S.J.11
Yang, J.H.12
Son, Y.I.13
Back, C.H.14
Han, J.15
Ree, H.J.16
Lee, E.S.17
Kim, S.H.18
Kim, D.W.19
Ahn, Y.C.20
Huh, S.J.21
Choe, Y.H.22
Lee, J.H.23
Park, M.H.24
Kong, G.S.25
Park, E.Y.26
Kang, Y.K.27
Bang, Y.J.28
Paik, N.S.29
Lee, S.N.30
Kim, S.31
Robbins, P.D.32
Tahara, H.33
Lotze, M.T.34
Park, C.H.35
more..
-
45
-
-
0030887047
-
Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies
-
Atkins, M. B., Robertson, M. J., Gordon, M., Lotze, M. T., DeCoste, M., DuBois, J. S., Ritz, J., Sandler, A. B., Edington, H. D., Garzone, P. D., Mier, J. W., Canning, C. M., Battiato, L., Tahara, H., and Sherman, M. L. Phase I evaluation of intravenous recombinant human interleukin 12 in patients with advanced malignancies. Clin. Cancer Res., 3: 409-417, 1997.
-
(1997)
Clin. Cancer Res.
, vol.3
, pp. 409-417
-
-
Atkins, M.B.1
Robertson, M.J.2
Gordon, M.3
Lotze, M.T.4
DeCoste, M.5
DuBois, J.S.6
Ritz, J.7
Sandler, A.B.8
Edington, H.D.9
Garzone, P.D.10
Mier, J.W.11
Canning, C.M.12
Battiato, L.13
Tahara, H.14
Sherman, M.L.15
-
46
-
-
0030766971
-
Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production
-
Leonard, J. P., Sherman, M. L., Fisher, G. L., Buchanan, L. J., Larsen, G., Atkins, M. B., Sosman, J. A., Dutcher, J. P., Vogelzang, N. J., and Ryan, J. L. Effects of single-dose interleukin-12 exposure on interleukin-12-associated toxicity and interferon-gamma production. Blood, 90: 2541-2548, 1997.
-
(1997)
Blood
, vol.90
, pp. 2541-2548
-
-
Leonard, J.P.1
Sherman, M.L.2
Fisher, G.L.3
Buchanan, L.J.4
Larsen, G.5
Atkins, M.B.6
Sosman, J.A.7
Dutcher, J.P.8
Vogelzang, N.J.9
Ryan, J.L.10
-
47
-
-
0035135745
-
Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12
-
Gollob, J. A., Veenstra, K. G., Mier, J. W., and Atkins, M. B. Agranulocytosis and hemolytic anemia in patients with renal cell cancer treated with interleukin-12. J. Immunother., 24: 91-98, 2001.
-
(2001)
J. Immunother.
, vol.24
, pp. 91-98
-
-
Gollob, J.A.1
Veenstra, K.G.2
Mier, J.W.3
Atkins, M.B.4
-
48
-
-
0033052143
-
The toxicology of interleukin-12: A review
-
Car, B. D., Eng, V. M., Lipman, J. M., and Anderson, T. D. The toxicology of interleukin-12: a review. Toxicol. Pathol., 27: 58-63, 1999.
-
(1999)
Toxicol. Pathol.
, vol.27
, pp. 58-63
-
-
Car, B.D.1
Eng, V.M.2
Lipman, J.M.3
Anderson, T.D.4
-
49
-
-
0031924595
-
Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma
-
Motzer, R. J., Rakhit, A., Schwartz, L. H., Olencki, T., Malone, T. M., Sandstrom, K., Nadeau, R., Parmar, H., and Bukowski, R. Phase I trial of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin. Cancer Res., 4: 1183-1191, 1998.
-
(1998)
Clin. Cancer Res.
, vol.4
, pp. 1183-1191
-
-
Motzer, R.J.1
Rakhit, A.2
Schwartz, L.H.3
Olencki, T.4
Malone, T.M.5
Sandstrom, K.6
Nadeau, R.7
Parmar, H.8
Bukowski, R.9
-
50
-
-
0027225601
-
Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing
-
Nouri, A. M., Hussain, R. F., Dos Santos, A. V., Mansouri, M., and Oliver, R. T. Intensity of class I antigen expression on human tumour cell lines and its relevance to the efficiency of non-MHC-restricted killing. Br. J. Cancer, 67: 1223-1228, 1993.
-
(1993)
Br. J. Cancer
, vol.67
, pp. 1223-1228
-
-
Nouri, A.M.1
Hussain, R.F.2
Dos Santos, A.V.3
Mansouri, M.4
Oliver, R.T.5
-
51
-
-
0027202727
-
Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12
-
Cesano, A., Visonneau, S., Clark, S. C., and Santoli, D. Cellular and molecular mechanisms of activation of MHC nonrestricted cytotoxic cells by IL-12. J. Immunol., 151: 2943-2957, 1993.
-
(1993)
J. Immunol.
, vol.151
, pp. 2943-2957
-
-
Cesano, A.1
Visonneau, S.2
Clark, S.C.3
Santoli, D.4
-
52
-
-
0019784850
-
F4/80, a monoclonal antibody directed specifically against the mouse macrophage
-
Austyn, J. M., and Gordon, S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur. J. Immunol., 11: 805-815, 1981.
-
(1981)
Eur. J. Immunol.
, vol.11
, pp. 805-815
-
-
Austyn, J.M.1
Gordon, S.2
-
53
-
-
0033568592
-
A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes
-
Warschkau, H., and Kiderlen, A. F. A monoclonal antibody directed against the murine macrophage surface molecule F4/80 modulates natural immune response to Listeria monocytogenes. J. Immunol., 163: 3409-3416, 1999.
-
(1999)
J. Immunol.
, vol.163
, pp. 3409-3416
-
-
Warschkau, H.1
Kiderlen, A.F.2
-
54
-
-
0032483682
-
Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents
-
Joseph, I. B., and Isaacs, J. T. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J. Natl. Cancer Inst., 90: 1648-1653, 1998.
-
(1998)
J. Natl. Cancer Inst.
, vol.90
, pp. 1648-1653
-
-
Joseph, I.B.1
Isaacs, J.T.2
|